Rovira Biscuit Corporation Recall: Undeclared colors FD&C Yellow #6, and FD&C Red 40

🇺🇸 United States

1. December 17, 2025 - Recall initiated
2. January 14, 2026 - Reported by source
3. April 7, 2026 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

H-0363-2026

Event ID

98174

Status

Terminated

Classification

Class II

Company

Rovira Biscuit Corporation

Product description

Tita Crackers Rovira, 3 (1/2 oz (15g) Foil Fresh Packets Net Wt.8 oz (226.8 g) boxes, 6/8oz boxes per case. UPC 072981005121 Tita Crackers Rovira, Net Wt. 24 oz (680 g) boxes, 6/24 oz boxes per case. UPC 072981005343 Tita Crackers Rovira, Net Wt 24 oz (680 g) cans, 6/24 oz boxes per case.

Quantity

29,246 units

Reason

Undeclared colors FD&C Yellow #6, and FD&C Red 40

Recall initiation date

December 17, 2025

Report date

January 14, 2026

Classification date

Not published in this source record

Termination date

April 7, 2026

Distribution pattern

GA, TX, MA, IL, MD, USVI and Puerto Rico. Foreign Panama and BVI

UPC, lot, and code information

UPC 072981005121; Lot numbers: 6/8oz 13125 21025 22425 31725 42125 42926 51925 61625 62325 70125 71425 72225 81125 90225 92225 100725 101424 110625 112224 Lot numbers: 6/24oz 13125 21025 22425 31725 42125 42926 51925 61625 62325 71425 72225 81125 90225 92225 100725 101424 110625 112224 120825 Lot number: 420/24 oz cans 110625

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

E-Mail

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Other products recalled under this same event

This recall shares FDA event ID 98174 with 5 other product entries in Public Health Trace.

Responsible company: Rovira Biscuit Corporation

Other recalls from Rovira Biscuit Corporation

A map highlighting the states named in the source's distribution description.

Distributed No data published

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map

State	Distributed
Georgia	1
Texas	1
Massachusetts	1
Illinois	1
Maryland	1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook